ZimVie (ZIMV) Competitors $14.29 +0.24 (+1.71%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZIMV vs. INMD, CDRE, MDXG, AORT, BLFS, RXST, EMBC, PLSE, ESTA, and LQDAShould you be buying ZimVie stock or one of its competitors? The main competitors of ZimVie include InMode (INMD), Cadre (CDRE), MiMedx Group (MDXG), Artivion (AORT), BioLife Solutions (BLFS), RxSight (RXST), Embecta (EMBC), Pulse Biosciences (PLSE), Establishment Labs (ESTA), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. ZimVie vs. InMode Cadre MiMedx Group Artivion BioLife Solutions RxSight Embecta Pulse Biosciences Establishment Labs Liquidia InMode (NASDAQ:INMD) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership, community ranking and risk. Is INMD or ZIMV more profitable? InMode has a net margin of 36.26% compared to ZimVie's net margin of -77.31%. InMode's return on equity of 21.46% beat ZimVie's return on equity.Company Net Margins Return on Equity Return on Assets InMode36.26% 21.46% 19.19% ZimVie -77.31%2.90%1.17% Do analysts prefer INMD or ZIMV? InMode currently has a consensus target price of $22.40, suggesting a potential upside of 33.41%. ZimVie has a consensus target price of $19.50, suggesting a potential upside of 36.46%. Given ZimVie's higher probable upside, analysts plainly believe ZimVie is more favorable than InMode.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InMode 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33ZimVie 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, INMD or ZIMV? InMode has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.11, indicating that its share price is 111% more volatile than the S&P 500. Does the MarketBeat Community believe in INMD or ZIMV? InMode received 158 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 73.85% of users gave InMode an outperform vote while only 18.75% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformInModeOutperform Votes16173.85% Underperform Votes5726.15% ZimVieOutperform Votes318.75%Underperform Votes1381.25% Does the media favor INMD or ZIMV? In the previous week, InMode had 1 more articles in the media than ZimVie. MarketBeat recorded 3 mentions for InMode and 2 mentions for ZimVie. ZimVie's average media sentiment score of 1.76 beat InMode's score of 0.21 indicating that ZimVie is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ZimVie 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders and institutionals have more ownership in INMD or ZIMV? 68.0% of InMode shares are owned by institutional investors. Comparatively, 95.6% of ZimVie shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 5.0% of ZimVie shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has higher valuation & earnings, INMD or ZIMV? InMode has higher revenue and earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInMode$492.05M2.87$197.92M$1.859.08ZimVie$457.43M0.86-$393.28M-$13.11-1.09 SummaryInMode beats ZimVie on 14 of the 17 factors compared between the two stocks. Get ZimVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIMV vs. The Competition Export to ExcelMetricZimVieDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$394.39M$1.08B$5.20B$9.14BDividend YieldN/A1.82%5.13%4.02%P/E RatioN/A25.7387.2517.09Price / Sales0.860.611,263.9177.22Price / Cash2.975.1643.7736.04Price / Book0.930.755.314.79Net Income-$393.28M-$33.08M$122.54M$224.99M7 Day Performance6.09%8.22%1.44%2.37%1 Month Performance5.07%13.82%2.51%4.40%1 Year Performance-19.81%360.07%25.32%20.10% ZimVie Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIMVZimVie2.9343 of 5 stars$14.29+1.7%$19.50+36.5%-19.8%$394.39M$457.43M0.002,600News CoveragePositive NewsINMDInMode3.1512 of 5 stars$15.81-0.6%$22.40+41.7%-25.7%$1.33B$423.75M8.55480CDRECadre2.4646 of 5 stars$32.03-0.1%$39.75+24.1%+13.5%$1.30B$516.16M38.592,240Analyst RevisionMDXGMiMedx Group2.5229 of 5 stars$8.60-0.6%$12.00+39.5%+12.0%$1.26B$342.80M15.64895Positive NewsAORTArtivion0.9978 of 5 stars$29.50-1.3%$31.80+7.8%+68.6%$1.24B$384.90M-1,475.001,300News CoverageBLFSBioLife Solutions2.4687 of 5 stars$26.64+0.1%$29.43+10.5%+52.2%$1.24B$146.96M-25.13440Short Interest ↑Gap DownRXSTRxSight3.8249 of 5 stars$30.01-10.2%$58.38+94.5%-33.7%$1.21B$128.29M-36.16220Gap DownHigh Trading VolumeEMBCEmbecta3.193 of 5 stars$19.72+1.2%$23.00+16.6%+10.3%$1.15B$1.12B14.612,200Positive NewsPLSEPulse Biosciences1.8093 of 5 stars$17.84-3.4%N/A+112.7%$1.10B$700,000.000.00140ESTAEstablishment Labs1.985 of 5 stars$35.31-22.9%$60.60+71.6%-4.8%$988.61M$153.07M-13.69960Gap DownHigh Trading VolumeLQDALiquidia2.9162 of 5 stars$11.63-4.6%$25.38+118.2%+0.0%$984.33M$15.61M-7.1350 Related Companies and Tools Related Companies InMode Competitors Cadre Competitors MiMedx Group Competitors Artivion Competitors BioLife Solutions Competitors RxSight Competitors Embecta Competitors Pulse Biosciences Competitors Establishment Labs Competitors Liquidia Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZIMV) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZimVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZimVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
